BCL2 and diabetic kidney disease: Furthermore, increasing Nrf2 levels are associated with a reduction in TNF, IL-6, Bax, and p38 levels, suppressed NFκB activation, and upregulated Bcl-2 expression, demonstrating anti-inflammatory and anti-apoptotic effects in STZ-induced DKD rats [431].